gram for new inhibitors against gpl20-CD4 binding from microorganisms, isochromophilones la (2) and Ila (3), which have the same azaphilone skeleton and chlorine as 1, were found as novel non-peptide inhibitors from a culture broth of Penicillium sp. FO-23383'4) (Chart 1). Although 1 was also found to be produced abundantly by the strain, its inhibitory activity against gpl20-CD4 binding was much less than that of 2 and 3. In order to understand the relationship between the structure and activity, we selected 1 as starting material to synthesize several derivatives, and determined their inhibitory activities against gpl20-CD4 binding.
Results
The comparison of the structures of sclerotiorin (1) with isochromophilone la (2) and isochromophilone Ha (3) suggested that the 7-O-group and carbon-8 may be To synthesize rubrorotiorin (9),2) we conducted an intermolecular esterification reaction between 4 and diketene, and then an intramolecular aldol condensation reaction of the above product (Scheme 2). From this reaction 10 was also obtained as by-product in 3% yield. The structure of these products were elucidated by MS, XH NMR, 13C NMR data, HMBC, HMQC and NOE. For the above products 5, 6, 7, 8 and 9, we conducted selective reduction of C-8, C-10 olefin as a,/?-unsaturated carbonyl compounds with Birch reduction or sodium hydrogen telluride reduction reagent,5'6) but didn't succeed. It may be due to several olefin bonds and lactone structure in these compounds are unstable to these reduction conditions.
The inhibitory activities against gpl20-CD4 binding of these products were determined. Table 1 shows that compounds 5, 8 and 9 inhibited gpl20-CD4 binding with IC50 of 2.6, 8.1, and 13/ig/ml, respectively. These values rank with those of2 and 3 (IC50: 2.75 and 1.51 /ig/ml, respectively). Compound 4 exhibited weaker inhibition (IC50: 39 /ig/ml), but compound 10 exhibited no inhibition at more than lOO^g/ml.
In conclusion, we have selected 1 as starting material to synthesize several isochromophilone analogues, and determined their inhibitory activities against gp l 20-CD4 5-Chloro-3-(3,5-dimethyll ,3-heptadienyl)-7-hydroxy-7-methyl-8-(ethoxycarbonylmethyliden)-6/7-2-benzopyran-6-one (5): 4 (400mg, 1.15mmol) was dissolved in anhydr.
ether (30ml), and Ph3P=CHCOOC2H5
(446 mg, 1.28 mmol) was added. The solution was stirred at room temperature for 5 hours, until no more starting material was found by TLC (w-hexane:acetone 3 : 1).
The solution was evaporated to dryness in vacuo. The residue was purified by silica gel column chromatography (rc-hexane:acetone 3 : 1) to yield 5 (340mg, 5-Chloro-3-(3 , 5-dimethyl-l ,3-heptadienyl)-7-hydroxy-7-methyl-8-(2-oxo-propyliden)-67/-2-benzopyran-6-one (6) 5-Chloro-3-(3,5-dimethyll ,3-heptadienyl)-7-acetylõ xy-7-methyl-8-(ethoxycarbonylmethyliden)-6//-2-benzopyran-6-one (7): To a solution of 5 (lOOmg, 0.24 mmol) in pyridine (20ml), acetic anhydride (122mg, 1.20mmol, 5eq) was added. The mixture was stirred at room temperature for 12hours.
The solution was poured into 0.5 n HC1 aq. (20ml) 9-Acetyl-5-chloro-3-(3,5-dimethyll ,3-heptadienyl)- 
